{"id":5889,"date":"2022-03-14T13:24:17","date_gmt":"2022-03-14T12:24:17","guid":{"rendered":"https:\/\/www.rapharm.eu\/hr\/?page_id=5889"},"modified":"2022-03-25T10:27:06","modified_gmt":"2022-03-25T09:27:06","slug":"novosti","status":"publish","type":"page","link":"https:\/\/www.rapharm.eu\/hr\/novosti\/","title":{"rendered":"Novosti"},"content":{"rendered":"<style type=\"text\/css\"> \n#cmsms_row_6a326510cfd3b .cmsms_row_outer_parent { \n\tpadding-top: 70px; \n} \n\n#cmsms_row_6a326510cfd3b .cmsms_row_outer_parent { \n\tpadding-bottom: 60px; \n} \n\n<\/style><div id=\"cmsms_row_6a326510cfd3b\" class=\"cmsms_row cmsms_color_scheme_default\">\n<div class=\"cmsms_row_outer_parent\">\n<div class=\"cmsms_row_outer\">\n<div class=\"cmsms_row_inner\">\n<div class=\"cmsms_row_margin\">\n<div class=\"cmsms_column one_first\">\n<div class=\"cmsms_wrap_blog entry-summary\" id=\"blog_6a326510d04ff\"><div class=\"blog standard\">\n<!--_________________________ Start Standard Article _________________________ -->\n\n<article id=\"post-6232\" class=\"cmsms_default_type post-6232 post type-post status-publish format-standard hentry category-novice-hr\">\n\t<div class=\"cmsms_post_cont\">\n\t<span class=\"cmsms_post_format_img cmsms_theme_icon_std\"><\/span><header class=\"cmsms_post_header entry-header\"><h2 class=\"cmsms_post_title entry-title\"><a href=\"https:\/\/www.rapharm.eu\/hr\/eu-novo-ogranicenje-sastojaka-u-dodacima-prehrani\/\">EU: Novo ograni\u010denje sastojaka u dodacima prehrani<\/a><\/h2><\/header><div class=\"cmsms_post_cont_info entry-meta\"><span class=\"cmsms_post_date\">Datum <abbr class=\"published\" title=\"03\/01\/2023\">03\/01\/2023<\/abbr><abbr class=\"dn date updated\" title=\"03\/01\/2023\">03\/01\/2023<\/abbr><\/span><\/div><div class=\"cmsms_post_content entry-content\">\n<p>U vezi s \u010dlankom 8. stavkom 2. Uredbe (EZ) br. 1925\/2006, Komisija je donijela Uredbu br. 2022\/2340, koja ograni\u010dava upotrebu...<\/p>\n<\/div>\n<footer class=\"cmsms_post_footer entry-meta\"><a class=\"cmsms_post_read_more\" href=\"https:\/\/www.rapharm.eu\/hr\/eu-novo-ogranicenje-sastojaka-u-dodacima-prehrani\/\">Pro\u010ditajte vi\u0161e<\/a><\/footer>\t<\/div>\n<\/article>\n<!--_________________________ Finish Standard Article _________________________ -->\n\n\n<!--_________________________ Start Standard Article _________________________ -->\n\n<article id=\"post-6221\" class=\"cmsms_default_type post-6221 post type-post status-publish format-standard hentry category-novice-hr\">\n\t<div class=\"cmsms_post_cont\">\n\t<span class=\"cmsms_post_format_img cmsms_theme_icon_std\"><\/span><header class=\"cmsms_post_header entry-header\"><h2 class=\"cmsms_post_title entry-title\"><a href=\"https:\/\/www.rapharm.eu\/hr\/eu-objavljene-dvije-nove-smjernice-koje-je-odobrio-mdcg\/\">EU: Objavljene dvije nove smjernice koje je odobrio MDCG<\/a><\/h2><\/header><div class=\"cmsms_post_cont_info entry-meta\"><span class=\"cmsms_post_date\">Datum <abbr class=\"published\" title=\"27\/10\/2022\">27\/10\/2022<\/abbr><abbr class=\"dn date updated\" title=\"03\/11\/2022\">03\/11\/2022<\/abbr><\/span><\/div><div class=\"cmsms_post_content entry-content\">\n<p>Dvije nove smjernice MDCG 2022-15 i MDCG 2021-22 rev.1 objavljene su 14. rujna na stranicama Europske komisije, a odobrila ih...<\/p>\n<\/div>\n<footer class=\"cmsms_post_footer entry-meta\"><a class=\"cmsms_post_read_more\" href=\"https:\/\/www.rapharm.eu\/hr\/eu-objavljene-dvije-nove-smjernice-koje-je-odobrio-mdcg\/\">Pro\u010ditajte vi\u0161e<\/a><\/footer>\t<\/div>\n<\/article>\n<!--_________________________ Finish Standard Article _________________________ -->\n\n\n<!--_________________________ Start Standard Article _________________________ -->\n\n<article id=\"post-6210\" class=\"cmsms_default_type post-6210 post type-post status-publish format-standard hentry category-novice-hr\">\n\t<div class=\"cmsms_post_cont\">\n\t<span class=\"cmsms_post_format_img cmsms_theme_icon_std\"><\/span><header class=\"cmsms_post_header entry-header\"><h2 class=\"cmsms_post_title entry-title\"><a href=\"https:\/\/www.rapharm.eu\/hr\/tvrdnje-o-ljepoti-naspram-zdravstvenih-tvrdnji-o-hrani\/\">Tvrdnje o ljepoti naspram zdravstvenih tvrdnji o hrani<\/a><\/h2><\/header><div class=\"cmsms_post_cont_info entry-meta\"><span class=\"cmsms_post_date\">Datum <abbr class=\"published\" title=\"18\/10\/2022\">18\/10\/2022<\/abbr><abbr class=\"dn date updated\" title=\"18\/10\/2022\">18\/10\/2022<\/abbr><\/span><\/div><div class=\"cmsms_post_content entry-content\">\n<p>U posljednjih godina dana bilje\u017ei se porast oboga\u0107ene hrane i dodataka prehrani koji prvenstveno ciljaju na \u017eensku populaciju s ciljem...<\/p>\n<\/div>\n<footer class=\"cmsms_post_footer entry-meta\"><a class=\"cmsms_post_read_more\" href=\"https:\/\/www.rapharm.eu\/hr\/tvrdnje-o-ljepoti-naspram-zdravstvenih-tvrdnji-o-hrani\/\">Pro\u010ditajte vi\u0161e<\/a><\/footer>\t<\/div>\n<\/article>\n<!--_________________________ Finish Standard Article _________________________ -->\n\n\n<!--_________________________ Start Standard Article _________________________ -->\n\n<article id=\"post-6196\" class=\"cmsms_default_type post-6196 post type-post status-publish format-standard hentry category-novice-hr category-uncategorized-hr\">\n\t<div class=\"cmsms_post_cont\">\n\t<span class=\"cmsms_post_format_img cmsms_theme_icon_std\"><\/span><header class=\"cmsms_post_header entry-header\"><h2 class=\"cmsms_post_title entry-title\"><a href=\"https:\/\/www.rapharm.eu\/hr\/eu-4-srpnja-2022-europska-komisija-donijela-je-provedbenu-uredbu-2022-1107-o-utvrdivanju-zajednickih-specifikacija-za-odredene-in-vitro-dijagnosticke-medicinske-proizvode-ivd-klase-d-u-skladu-s-u\/\">EU: 4. srpnja 2022. Europska komisija donijela je Provedbenu uredbu 2022\/1107 o utvr\u0111ivanju zajedni\u010dkih specifikacija za odre\u0111ene in vitro dijagnosti\u010dke medicinske proizvode (IVD) klase D u skladu s Uredbom (EU) 2017\/746<\/a><\/h2><\/header><div class=\"cmsms_post_cont_info entry-meta\"><span class=\"cmsms_post_date\">Datum <abbr class=\"published\" title=\"11\/07\/2022\">11\/07\/2022<\/abbr><abbr class=\"dn date updated\" title=\"11\/07\/2022\">11\/07\/2022<\/abbr><\/span><\/div><div class=\"cmsms_post_content entry-content\">\n<p>Europska komisija u dokumentu obja\u0161njava, da za neke IVD klase D ne postoje uskla\u0111ene norme. Me\u0111utim, budu\u0107i da je odgovornost...<\/p>\n<\/div>\n<footer class=\"cmsms_post_footer entry-meta\"><a class=\"cmsms_post_read_more\" href=\"https:\/\/www.rapharm.eu\/hr\/eu-4-srpnja-2022-europska-komisija-donijela-je-provedbenu-uredbu-2022-1107-o-utvrdivanju-zajednickih-specifikacija-za-odredene-in-vitro-dijagnosticke-medicinske-proizvode-ivd-klase-d-u-skladu-s-u\/\">Pro\u010ditajte vi\u0161e<\/a><\/footer>\t<\/div>\n<\/article>\n<!--_________________________ Finish Standard Article _________________________ -->\n\n\n<!--_________________________ Start Standard Article _________________________ -->\n\n<article id=\"post-6187\" class=\"cmsms_default_type post-6187 post type-post status-publish format-standard hentry category-novice-hr category-uncategorized-hr\">\n\t<div class=\"cmsms_post_cont\">\n\t<span class=\"cmsms_post_format_img cmsms_theme_icon_std\"><\/span><header class=\"cmsms_post_header entry-header\"><h2 class=\"cmsms_post_title entry-title\"><a href=\"https:\/\/www.rapharm.eu\/hr\/eu-mdcg-je-objavio-dokument-o-stajalistu\/\">EU: MDCG je objavio dokument o stajali\u0161tu<\/a><\/h2><\/header><div class=\"cmsms_post_cont_info entry-meta\"><span class=\"cmsms_post_date\">Datum <abbr class=\"published\" title=\"21\/06\/2022\">21\/06\/2022<\/abbr><abbr class=\"dn date updated\" title=\"24\/06\/2022\">24\/06\/2022<\/abbr><\/span><\/div><div class=\"cmsms_post_content entry-content\">\n<p>Dokument o stajali\u0161tu MDCG-a 2022-11 objavljen je na web stranici Europske komisije u lipnju, i odobren od strane Koordinacijske skupine...<\/p>\n<\/div>\n<footer class=\"cmsms_post_footer entry-meta\"><a class=\"cmsms_post_read_more\" href=\"https:\/\/www.rapharm.eu\/hr\/eu-mdcg-je-objavio-dokument-o-stajalistu\/\">Pro\u010ditajte vi\u0161e<\/a><\/footer>\t<\/div>\n<\/article>\n<!--_________________________ Finish Standard Article _________________________ -->\n\n\n<!--_________________________ Start Standard Article _________________________ -->\n\n<article id=\"post-6179\" class=\"cmsms_default_type post-6179 post type-post status-publish format-standard hentry category-novice-hr category-uncategorized-hr\">\n\t<div class=\"cmsms_post_cont\">\n\t<span class=\"cmsms_post_format_img cmsms_theme_icon_std\"><\/span><header class=\"cmsms_post_header entry-header\"><h2 class=\"cmsms_post_title entry-title\"><a href=\"https:\/\/www.rapharm.eu\/hr\/eu-mdcg-je-odobrio-novu-smjernicu\/\">EU: MDCG je odobrio novu smjernicu<\/a><\/h2><\/header><div class=\"cmsms_post_cont_info entry-meta\"><span class=\"cmsms_post_date\">Datum <abbr class=\"published\" title=\"17\/06\/2022\">17\/06\/2022<\/abbr><abbr class=\"dn date updated\" title=\"17\/06\/2022\">17\/06\/2022<\/abbr><\/span><\/div><div class=\"cmsms_post_content entry-content\">\n<p>Nova MDCG smjernica 2022-8 objavljena je na web stranici Europske komisije u svibnju i odobrena od strane Koordinacijske skupine za...<\/p>\n<\/div>\n<footer class=\"cmsms_post_footer entry-meta\"><a class=\"cmsms_post_read_more\" href=\"https:\/\/www.rapharm.eu\/hr\/eu-mdcg-je-odobrio-novu-smjernicu\/\">Pro\u010ditajte vi\u0161e<\/a><\/footer>\t<\/div>\n<\/article>\n<!--_________________________ Finish Standard Article _________________________ -->\n\n\n<!--_________________________ Start Standard Article _________________________ -->\n\n<article id=\"post-6170\" class=\"cmsms_default_type post-6170 post type-post status-publish format-standard hentry category-novice-hr category-uncategorized-hr\">\n\t<div class=\"cmsms_post_cont\">\n\t<span class=\"cmsms_post_format_img cmsms_theme_icon_std\"><\/span><header class=\"cmsms_post_header entry-header\"><h2 class=\"cmsms_post_title entry-title\"><a href=\"https:\/\/www.rapharm.eu\/hr\/eu-obustavljena-procjena-kanabidiola-cbd-kao-nove-hrane\/\">EU: Obustavljena procjena kanabidiola (CBD) kao nove hrane<\/a><\/h2><\/header><div class=\"cmsms_post_cont_info entry-meta\"><span class=\"cmsms_post_date\">Datum <abbr class=\"published\" title=\"15\/06\/2022\">15\/06\/2022<\/abbr><abbr class=\"dn date updated\" title=\"15\/06\/2022\">15\/06\/2022<\/abbr><\/span><\/div><div class=\"cmsms_post_content entry-content\">\n<p>Europska agencija za sigurnost hrane (EFSA) obustavlja ocjenjivanje CBD-a kao nove hrane, budu\u0107i da trenuta\u010dna znanstvena dokumentacija ne utvr\u0111uje sigurnost...<\/p>\n<\/div>\n<footer class=\"cmsms_post_footer entry-meta\"><a class=\"cmsms_post_read_more\" href=\"https:\/\/www.rapharm.eu\/hr\/eu-obustavljena-procjena-kanabidiola-cbd-kao-nove-hrane\/\">Pro\u010ditajte vi\u0161e<\/a><\/footer>\t<\/div>\n<\/article>\n<!--_________________________ Finish Standard Article _________________________ -->\n\n\n<!--_________________________ Start Standard Article _________________________ -->\n\n<article id=\"post-6159\" class=\"cmsms_default_type post-6159 post type-post status-publish format-standard hentry category-novice-hr category-uncategorized-hr\">\n\t<div class=\"cmsms_post_cont\">\n\t<span class=\"cmsms_post_format_img cmsms_theme_icon_std\"><\/span><header class=\"cmsms_post_header entry-header\"><h2 class=\"cmsms_post_title entry-title\"><a href=\"https:\/\/www.rapharm.eu\/hr\/6159\/\">EU: Objavljene su dvije nove smjernice koje je odobrio MDCG<\/a><\/h2><\/header><div class=\"cmsms_post_cont_info entry-meta\"><span class=\"cmsms_post_date\">Datum <abbr class=\"published\" title=\"07\/06\/2022\">07\/06\/2022<\/abbr><abbr class=\"dn date updated\" title=\"08\/06\/2022\">08\/06\/2022<\/abbr><\/span><\/div><div class=\"cmsms_post_content entry-content\">\n<p>Dvije nove smjernice, MDCG 2022-9 i MDCG 2022-10, objavljene su u svibnju na web stranici Europske komisije kojima se podr\u017eava...<\/p>\n<\/div>\n<footer class=\"cmsms_post_footer entry-meta\"><a class=\"cmsms_post_read_more\" href=\"https:\/\/www.rapharm.eu\/hr\/6159\/\">Pro\u010ditajte vi\u0161e<\/a><\/footer>\t<\/div>\n<\/article>\n<!--_________________________ Finish Standard Article _________________________ -->\n\n\n<!--_________________________ Start Standard Article _________________________ -->\n\n<article id=\"post-6140\" class=\"cmsms_default_type post-6140 post type-post status-publish format-standard hentry category-novice-hr category-uncategorized-hr\">\n\t<div class=\"cmsms_post_cont\">\n\t<span class=\"cmsms_post_format_img cmsms_theme_icon_std\"><\/span><header class=\"cmsms_post_header entry-header\"><h2 class=\"cmsms_post_title entry-title\"><a href=\"https:\/\/www.rapharm.eu\/hr\/eu-status-eu-svicarskog-sporazuma-o-medusobnom-priznavanju-mra-za-in-vitro-dijagnosticke-medicinske-proizvode\/\">EU: Status EU-\u0160vicarskog sporazuma o me\u0111usobnom priznavanju (MRA) za in vitro dijagnosti\u010dke medicinske proizvode<\/a><\/h2><\/header><div class=\"cmsms_post_cont_info entry-meta\"><span class=\"cmsms_post_date\">Datum <abbr class=\"published\" title=\"06\/06\/2022\">06\/06\/2022<\/abbr><abbr class=\"dn date updated\" title=\"06\/06\/2022\">06\/06\/2022<\/abbr><\/span><\/div><div class=\"cmsms_post_content entry-content\">\n<p>\u0160vicarska sudjeluje na unutarnjem tr\u017ei\u0161tu Europske unije kroz Sporazum o me\u0111usobnom priznavanju u vezi s ocjenom sukladnosti (MRA). Budu\u0107i da...<\/p>\n<\/div>\n<footer class=\"cmsms_post_footer entry-meta\"><a class=\"cmsms_post_read_more\" href=\"https:\/\/www.rapharm.eu\/hr\/eu-status-eu-svicarskog-sporazuma-o-medusobnom-priznavanju-mra-za-in-vitro-dijagnosticke-medicinske-proizvode\/\">Pro\u010ditajte vi\u0161e<\/a><\/footer>\t<\/div>\n<\/article>\n<!--_________________________ Finish Standard Article _________________________ -->\n\n\n<!--_________________________ Start Standard Article _________________________ -->\n\n<article id=\"post-6131\" class=\"cmsms_default_type post-6131 post type-post status-publish format-standard hentry category-novice-hr category-uncategorized-hr\">\n\t<div class=\"cmsms_post_cont\">\n\t<span class=\"cmsms_post_format_img cmsms_theme_icon_std\"><\/span><header class=\"cmsms_post_header entry-header\"><h2 class=\"cmsms_post_title entry-title\"><a href=\"https:\/\/www.rapharm.eu\/hr\/eu-objavljene-su-nove-uskladene-norme-za-mdr-i-ivdr-regulativu\/\">EU: Objavljene su nove uskla\u0111ene norme za MDR i IVDR regulativu<\/a><\/h2><\/header><div class=\"cmsms_post_cont_info entry-meta\"><span class=\"cmsms_post_date\">Datum <abbr class=\"published\" title=\"27\/05\/2022\">27\/05\/2022<\/abbr><abbr class=\"dn date updated\" title=\"27\/05\/2022\">27\/05\/2022<\/abbr><\/span><\/div><div class=\"cmsms_post_content entry-content\">\n<p>Provedbene odluke Komisije (EU) 2022\/757 o novim uskla\u0111enim normama za MDR i 2022\/729 o novim uskla\u0111enim normama za IVDR objavljene...<\/p>\n<\/div>\n<footer class=\"cmsms_post_footer entry-meta\"><a class=\"cmsms_post_read_more\" href=\"https:\/\/www.rapharm.eu\/hr\/eu-objavljene-su-nove-uskladene-norme-za-mdr-i-ivdr-regulativu\/\">Pro\u010ditajte vi\u0161e<\/a><\/footer>\t<\/div>\n<\/article>\n<!--_________________________ Finish Standard Article _________________________ -->\n\n\n<!--_________________________ Start Standard Article _________________________ -->\n\n<article id=\"post-6120\" class=\"cmsms_default_type post-6120 post type-post status-publish format-standard hentry category-novice-hr category-uncategorized-hr\">\n\t<div class=\"cmsms_post_cont\">\n\t<span class=\"cmsms_post_format_img cmsms_theme_icon_std\"><\/span><header class=\"cmsms_post_header entry-header\"><h2 class=\"cmsms_post_title entry-title\"><a href=\"https:\/\/www.rapharm.eu\/hr\/eu-objavljene-su-dvije-nove-smjernice-koje-je-odobrio-mdcg\/\">EU: Objavljene su dvije nove smjernice koje je odobrio MDCG<\/a><\/h2><\/header><div class=\"cmsms_post_cont_info entry-meta\"><span class=\"cmsms_post_date\">Datum <abbr class=\"published\" title=\"12\/05\/2022\">12\/05\/2022<\/abbr><abbr class=\"dn date updated\" title=\"16\/05\/2022\">16\/05\/2022<\/abbr><\/span><\/div><div class=\"cmsms_post_content entry-content\">\n<p>Dvije nove smjernice, MDCG 2022-5 i MDCG 2022-6, nedavno su objavljene na web stranici Europske komisije, koje je podr\u017eala Koordinacijska...<\/p>\n<\/div>\n<footer class=\"cmsms_post_footer entry-meta\"><a class=\"cmsms_post_read_more\" href=\"https:\/\/www.rapharm.eu\/hr\/eu-objavljene-su-dvije-nove-smjernice-koje-je-odobrio-mdcg\/\">Pro\u010ditajte vi\u0161e<\/a><\/footer>\t<\/div>\n<\/article>\n<!--_________________________ Finish Standard Article _________________________ -->\n\n\n<!--_________________________ Start Standard Article _________________________ -->\n\n<article id=\"post-6109\" class=\"cmsms_default_type post-6109 post type-post status-publish format-standard hentry category-novice-hr category-uncategorized-hr\">\n\t<div class=\"cmsms_post_cont\">\n\t<span class=\"cmsms_post_format_img cmsms_theme_icon_std\"><\/span><header class=\"cmsms_post_header entry-header\"><h2 class=\"cmsms_post_title entry-title\"><a href=\"https:\/\/www.rapharm.eu\/hr\/eu-uz-stupanje-na-snagu-prethodno-pripremljenih-dijelova-zakonodavstva-iz-podrucja-lijekova-2022-godinu-obiljezavaju-pripreme-za-izmjene-opce-uredbe-iz-podrucja-lijekova\/\">EU: Uz stupanje na snagu prethodno pripremljenih dijelova zakonodavstva iz podru\u010dja lijekova, 2022. godinu obilje\u017eavaju pripreme za izmjene op\u0107e uredbe iz podru\u010dja lijekova<\/a><\/h2><\/header><div class=\"cmsms_post_cont_info entry-meta\"><span class=\"cmsms_post_date\">Datum <abbr class=\"published\" title=\"03\/05\/2022\">03\/05\/2022<\/abbr><abbr class=\"dn date updated\" title=\"12\/05\/2022\">12\/05\/2022<\/abbr><\/span><\/div><div class=\"cmsms_post_content entry-content\">\n<p>28. sije\u010dnja 2022. na snagu je stupio novi zakon u podru\u010dju veterinarskih lijekova, \u010diji je cilj prilagodba propisa aktualnim izazovima,...<\/p>\n<\/div>\n<footer class=\"cmsms_post_footer entry-meta\"><a class=\"cmsms_post_read_more\" href=\"https:\/\/www.rapharm.eu\/hr\/eu-uz-stupanje-na-snagu-prethodno-pripremljenih-dijelova-zakonodavstva-iz-podrucja-lijekova-2022-godinu-obiljezavaju-pripreme-za-izmjene-opce-uredbe-iz-podrucja-lijekova\/\">Pro\u010ditajte vi\u0161e<\/a><\/footer>\t<\/div>\n<\/article>\n<!--_________________________ Finish Standard Article _________________________ -->\n\n<\/div><div class=\"cmsms_wrap_more_posts\"><div class=\"cmsms_wrap_pagination\"><ul class='page-numbers'>\n\t<li><span aria-current=\"page\" class=\"page-numbers current\">1<\/span><\/li>\n\t<li><a class=\"page-numbers\" href=\"https:\/\/www.rapharm.eu\/hr\/wp-json\/wp\/v2\/pages\/5889\/page\/2\/\">2<\/a><\/li>\n\t<li><a class=\"next page-numbers\" href=\"https:\/\/www.rapharm.eu\/hr\/wp-json\/wp\/v2\/pages\/5889\/page\/2\/\"><span class=\"cmsms_theme_icon_slide_next\"><\/span><\/a><\/li>\n<\/ul>\n<\/div><\/div><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-5889","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Novosti - raPHARM<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rapharm.eu\/novice\/\" \/>\n<meta property=\"og:locale\" content=\"hr_HR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Novosti - raPHARM\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rapharm.eu\/novice\/\" \/>\n<meta property=\"og:site_name\" content=\"raPHARM\" \/>\n<meta property=\"article:modified_time\" content=\"2022-03-25T09:27:06+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.rapharm.eu\/novice\/\",\"url\":\"https:\/\/www.rapharm.eu\/novice\/\",\"name\":\"Novosti - raPHARM\",\"isPartOf\":{\"@id\":\"https:\/\/www.rapharm.eu\/#website\"},\"datePublished\":\"2022-03-14T12:24:17+00:00\",\"dateModified\":\"2022-03-25T09:27:06+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.rapharm.eu\/novice\/#breadcrumb\"},\"inLanguage\":\"hr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.rapharm.eu\/novice\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.rapharm.eu\/novice\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.rapharm.eu\/hr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Novosti\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.rapharm.eu\/#website\",\"url\":\"https:\/\/www.rapharm.eu\/\",\"name\":\"raPHARM\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.rapharm.eu\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"hr\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Novosti - raPHARM","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rapharm.eu\/novice\/","og_locale":"hr_HR","og_type":"article","og_title":"Novosti - raPHARM","og_url":"https:\/\/www.rapharm.eu\/novice\/","og_site_name":"raPHARM","article_modified_time":"2022-03-25T09:27:06+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.rapharm.eu\/novice\/","url":"https:\/\/www.rapharm.eu\/novice\/","name":"Novosti - raPHARM","isPartOf":{"@id":"https:\/\/www.rapharm.eu\/#website"},"datePublished":"2022-03-14T12:24:17+00:00","dateModified":"2022-03-25T09:27:06+00:00","breadcrumb":{"@id":"https:\/\/www.rapharm.eu\/novice\/#breadcrumb"},"inLanguage":"hr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rapharm.eu\/novice\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.rapharm.eu\/novice\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.rapharm.eu\/hr\/"},{"@type":"ListItem","position":2,"name":"Novosti"}]},{"@type":"WebSite","@id":"https:\/\/www.rapharm.eu\/#website","url":"https:\/\/www.rapharm.eu\/","name":"raPHARM","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rapharm.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"hr"}]}},"_links":{"self":[{"href":"https:\/\/www.rapharm.eu\/hr\/wp-json\/wp\/v2\/pages\/5889","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rapharm.eu\/hr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.rapharm.eu\/hr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.rapharm.eu\/hr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rapharm.eu\/hr\/wp-json\/wp\/v2\/comments?post=5889"}],"version-history":[{"count":4,"href":"https:\/\/www.rapharm.eu\/hr\/wp-json\/wp\/v2\/pages\/5889\/revisions"}],"predecessor-version":[{"id":5945,"href":"https:\/\/www.rapharm.eu\/hr\/wp-json\/wp\/v2\/pages\/5889\/revisions\/5945"}],"wp:attachment":[{"href":"https:\/\/www.rapharm.eu\/hr\/wp-json\/wp\/v2\/media?parent=5889"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}